EHR Documentation May Help in Harm Reduction Initiatives

This article originally appeared here.
Share this content:
EHR Documentation May Help in Harm Reduction Initiatives
EHR Documentation May Help in Harm Reduction Initiatives

THURSDAY, April 27, 2017 (HealthDay News) -- Electronic health record (EHR) documentation can be used to reduce preventable harm in hospitals, according to a study published online April 27 in Pediatrics.

Daniel Hyman, M.D., from Children's Hospital Colorado in Aurora, and colleagues used EHR documentation to enable decision support, data capture, and auditing and implemented reporting tools to expedite early identification of patients at risk and provide timely intervention. Strategies to reduce harm included aggregating data to generate a risk profile for hospital-acquired conditions (HACs) for all inpatients. The risk profile included links to prevention bundles and care guidelines. Real-time dashboards of bundle compliance were populated with data from observational audits and EHR documentation. The discussion of relevant HAC prevention measures during patient care and unit leadership rounds was promoted via patient population summary reports.

The researchers found that since 2012, the hospital had experienced a more than 30 percent reduction in harm for nine types of HACs. The number of HACs with more than 80 percent bundle adherence doubled in 2014, coinciding with the progressive rollout of these EHR interventions.

"Existing EHR documentation and reporting tools may be effective adjuncts to harm reduction initiatives," the authors write. "Additional study should include an evaluation of scalability across organizations, ongoing bundle adherence, and individual tests of change to isolate interventions with the highest impact on our results."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »